EdenteV2, France, Analysis, bibRecord, 000329

Response rate in second-line therapy of a new fixed combination metformin/glibenclamide product

Identifieur interne : 000329 ( France/Analysis ); précédent : 000328; suivant : 000330

Response rate in second-line therapy of a new fixed combination metformin/glibenclamide product

Auteurs : M. Marre [France] ; Th Allavoine [France]

Source :

Diabetes Research and Clinical Practice [ 0168-8227 ] ; 2000.

RBID : ISTEX:D9B54737F0E8D44DC122064090C39BF981658E96

Descripteurs français

Wicri :
- topic : Diabète, Glucose.

English descriptors

Url:

https://api.istex.fr/document/D9B54737F0E8D44DC122064090C39BF981658E96/fulltext/pdf

DOI: 10.1016/S0168-8227(00)81173-0

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: 006C02
to stream Istex, to step Curation: 006C02
to stream Istex, to step Checkpoint: 003D39
to stream Main, to step Merge: 009080
to stream Main, to step Curation: 008D01
to stream Main, to step Exploration: 008D01
to stream France, to step Extraction: 000329

Links to Exploration step

ISTEX:D9B54737F0E8D44DC122064090C39BF981658E96

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Response rate in second-line therapy of a new fixed combination metformin/glibenclamide product</title>
<author><name sortKey="Marre, M" sort="Marre, M" uniqKey="Marre M" first="M" last="Marre">M. Marre</name>
</author>
<author><name sortKey="Allavoine, Th" sort="Allavoine, Th" uniqKey="Allavoine T" first="Th" last="Allavoine">Th Allavoine</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D9B54737F0E8D44DC122064090C39BF981658E96</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1016/S0168-8227(00)81173-0</idno>
<idno type="url">https://api.istex.fr/document/D9B54737F0E8D44DC122064090C39BF981658E96/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">006C02</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">006C02</idno>
<idno type="wicri:Area/Istex/Curation">006C02</idno>
<idno type="wicri:Area/Istex/Checkpoint">003D39</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">003D39</idno>
<idno type="wicri:doubleKey">0168-8227:2000:Marre M:response:rate:in</idno>
<idno type="wicri:Area/Main/Merge">009080</idno>
<idno type="wicri:Area/Main/Curation">008D01</idno>
<idno type="wicri:Area/Main/Exploration">008D01</idno>
<idno type="wicri:Area/France/Extraction">000329</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Response rate in second-line therapy of a new fixed combination metformin/glibenclamide product</title>
<author><name sortKey="Marre, M" sort="Marre, M" uniqKey="Marre M" first="M" last="Marre">M. Marre</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Lyon; Bichat Hospital, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Allavoine, Th" sort="Allavoine, Th" uniqKey="Allavoine T" first="Th" last="Allavoine">Th Allavoine</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Lyon; Bichat Hospital, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Diabetes Research and Clinical Practice</title>
<title level="j" type="abbrev">DIAB</title>
<idno type="ISSN">0168-8227</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="2000">2000</date>
<biblScope unit="volume">50</biblScope>
<biblScope unit="supplement">S1</biblScope>
<biblScope unit="page" from="343">343</biblScope>
</imprint>
<idno type="ISSN">0168-8227</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0168-8227</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Ababa</term>
<term>Abnormal liver function tests</term>
<term>Addis ababa</term>
<term>Beer sheva</term>
<term>Bone loss</term>
<term>Caries</term>
<term>Clinical examination</term>
<term>Combination tablet dosages</term>
<term>Control subjects</term>
<term>Dental caries</term>
<term>Diabetes</term>
<term>Diabetes clinic</term>
<term>Diabetes mellitus</term>
<term>Diabetes mellitus centre</term>
<term>Diabetes patients</term>
<term>Diabetic</term>
<term>Diabetic patients</term>
<term>Eastern hospital</term>
<term>Failure patients</term>
<term>Fasting plasma glucose</term>
<term>Fatty liver</term>
<term>Final dose</term>
<term>First month</term>
<term>France objective</term>
<term>Gingival recession</term>
<term>Glucose</term>
<term>Glycaemic</term>
<term>Group control</term>
<term>Homa</term>
<term>Homeostasis model assessment</term>
<term>Hong kong</term>
<term>Inadequate glycaemic control</term>
<term>Insulin resistance</term>
<term>Linear regression analysis</term>
<term>Liver cirrhosis</term>
<term>Liver function abnormalities</term>
<term>Mellitus</term>
<term>Metformin</term>
<term>Mmol</term>
<term>Monotherapy</term>
<term>Oral cavity</term>
<term>Periodontal</term>
<term>Periodontal disease</term>
<term>Periodontal problems</term>
<term>Plasma glucose</term>
<term>Predicate test strips</term>
<term>Primary objective</term>
<term>Randomised</term>
<term>Response rates</term>
<term>Self glucose monitoring</term>
<term>Significant association</term>
<term>Test strip</term>
<term>Test strip results</term>
<term>Western negev</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Ababa</term>
<term>Abnormal liver function tests</term>
<term>Addis ababa</term>
<term>Beer sheva</term>
<term>Bone loss</term>
<term>Caries</term>
<term>Clinical examination</term>
<term>Combination tablet dosages</term>
<term>Control subjects</term>
<term>Dental caries</term>
<term>Diabetes</term>
<term>Diabetes clinic</term>
<term>Diabetes mellitus</term>
<term>Diabetes mellitus centre</term>
<term>Diabetes patients</term>
<term>Diabetic</term>
<term>Diabetic patients</term>
<term>Eastern hospital</term>
<term>Failure patients</term>
<term>Fasting plasma glucose</term>
<term>Fatty liver</term>
<term>Final dose</term>
<term>First month</term>
<term>France objective</term>
<term>Gingival recession</term>
<term>Glucose</term>
<term>Glycaemic</term>
<term>Group control</term>
<term>Homa</term>
<term>Homeostasis model assessment</term>
<term>Hong kong</term>
<term>Inadequate glycaemic control</term>
<term>Insulin resistance</term>
<term>Linear regression analysis</term>
<term>Liver cirrhosis</term>
<term>Liver function abnormalities</term>
<term>Mellitus</term>
<term>Metformin</term>
<term>Mmol</term>
<term>Monotherapy</term>
<term>Oral cavity</term>
<term>Periodontal</term>
<term>Periodontal disease</term>
<term>Periodontal problems</term>
<term>Plasma glucose</term>
<term>Predicate test strips</term>
<term>Primary objective</term>
<term>Randomised</term>
<term>Response rates</term>
<term>Self glucose monitoring</term>
<term>Significant association</term>
<term>Test strip</term>
<term>Test strip results</term>
<term>Western negev</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Diabète</term>
<term>Glucose</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
</settlement>
</list>
<tree><country name="France"><region name="Île-de-France"><name sortKey="Marre, M" sort="Marre, M" uniqKey="Marre M" first="M" last="Marre">M. Marre</name>
</region>
<name sortKey="Allavoine, Th" sort="Allavoine, Th" uniqKey="Allavoine T" first="Th" last="Allavoine">Th Allavoine</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/France/Analysis

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000329 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000329 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    EdenteV2
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:D9B54737F0E8D44DC122064090C39BF981658E96
   |texte=   Response rate in second-line therapy of a new fixed combination metformin/glibenclamide product
}}

This area was generated with Dilib version V0.6.32.
Data generation: Thu Nov 30 15:26:48 2017. Site generation: Tue Mar 8 16:36:20 2022

	Serveur d'exploration sur le patient édenté
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le patient édenté

Response rate in second-line therapy of a new fixed combination metformin/glibenclamide product

Response rate in second-line therapy of a new fixed combination metformin/glibenclamide product

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri